tiprankstipranks

Lindsay Rosenwald Insider Profile

18 Followers
Lindsay Rosenwald, Pres, CEO & COB, Director, Ten Percent Owner at Fortress Biotech, holds 2.89M shares in Fortress Biotech (Ticker: FBIO), holds 132.17K shares in Checkpoint Therapeutics (Ticker: CKPT), holds 320.71K shares in Journey Medical Corp (Ticker: DERM). Most recently, Lindsay Rosenwald Bought ― shares of Fortress Biotech on Jul 01, 2024 for an estimated value of 32.60K.
tipranks
Lindsay Rosenwald

Lindsay Rosenwald
Fortress Biotech (FBIO)
Pres, CEO & COB, Director, Ten Percent Owner

Ranked #78,391 out of 97,944 Corporate Insiders

Profitable Transactions

37%
7 out of 19 Profitable Transactions

Average Return

-9.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$106M
92.13%
4.56%
1.59%
1.14%
0.58% Others
A breakdown of Lindsay Rosenwald's holdings

Insider Roles

TG Therapeutics
(TGTX)
Ten Percent Owner
Fortress Biotech
(FBIO)
Pres, CEO & COB, Director, Ten Percent Owner
Journey Medical Corp
(DERM)
Director
Avenue Therapeutics
(ATXI)
Director
+3 other positions
Roles that Lindsay Rosenwald holds in companies

Most Profitable Insider Trade

Stock:
Fortress Biotech
(FBIO)
Rating:Informative Buy
Date:Nov 10, 2014 - Nov 10, 2015
Return:+101.90%
The most profitable trade made by Lindsay Rosenwald

Lindsay Rosenwald's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fortress Biotech
Jul 01, 2024
Pres, CEO & COB, Director, Ten Percent Owner
Informative Buy
32.60K
$4.83M
Avenue Therapeutics
Sep 12, 2023
Director
Informative Buy
251.05K
$1.21M
Checkpoint Therapeutics
May 16, 2024
Director
Uninformative Buy
$281.53K
Mustang Bio
Jul 07, 2023
Director
Uninformative Buy
$33.83K
Journey Medical Corp
Mar 27, 2024
Director
Informative Buy
30.40K
$1.68M
OACQF
Origo Acquisition Corporation
May 23, 2016
Uninformative Sell
TG Therapeutics
Ten Percent Owner
$97.63M
KERX
Keryx Biopharma
$6.91M
Alaunos Therapeutics
Ten Percent Owner
$300.31K
List of latest transactions for each holding click on a transaction to see Lindsay Rosenwald's performance on stock

Lindsay Rosenwald insider profile FAQ

What is the percentage of profitable transactions made by Lindsay Rosenwald?
The percentage of profitable transactions made by Lindsay Rosenwald is 37%.
    What is the average return per transaction made by Lindsay Rosenwald?
    The average return per transaction made by Lindsay Rosenwald is -9.90%.
      What stocks does Lindsay Rosenwald hold?
      Lindsay Rosenwald holds: FBIO, ATXI, CKPT, MBIO, DERM, OACQF, TGTX, KERX, TCRT stocks.
        What was Lindsay Rosenwald’s latest transaction?
        Lindsay Rosenwald latest transaction was an Informative Buy of $32.60K.
          What was Lindsay Rosenwald's most profitable transaction?
          Lindsay Rosenwald’s most profitable transaction was an Informative Buy of FBIO stock on November 10, 2014. The return on the trade was 101.90%.
            What is Lindsay Rosenwald's role in Fortress Biotech?
            Lindsay Rosenwald's role in Fortress Biotech is Pres, CEO & COB, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.